TPST Tempest Therapeutics, Inc.: institutional ownership and insider trading
22 funds reported holding $1.61M of Tempest Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $563K, with 4 new positions and 5 funds selling out; over the last 12 months insiders bought $1.00M and sold $0 on the open market.
Famous investors holding TPST
- Ken Griffin (Citadel Advisors): $22.0K, 0.0% of the portfolio
Largest institutional holders of TPST
- SABBY MANAGEMENT, LLC — $568K
- VANGUARD GROUP INC — $467K
- VANGUARD CAPITAL MANAGEMENT LLC — $260K
- GEODE CAPITAL MANAGEMENT, LLC — $96.2K
- VANGUARD FIDUCIARY TRUST CO — $76.5K
- BlackRock, Inc. (BLK) — $43.4K
- Squarepoint Ops LLC — $34.3K
- NORTHERN TRUST CORP (NTRS, NTRSO) — $22.4K
- CITADEL ADVISORS LLC — $22.0K
- UBS Group AG (UBS) — $6.26K
Recent TPST insider trades
- Mar 24, 2026: Angel Matthew bought 231,482 shares ($500K)
- Mar 24, 2026: Angel Matthew bought 231,482 shares ($500K)
5%+ owners
- Matthew Angel: 37.4% (Schedule 13D/A, filed Mar 25, 2026)